Literature DB >> 16906129

Formation of GW bodies is a consequence of microRNA genesis.

Kaleb M Pauley1, Theophany Eystathioy, Andrew Jakymiw, John C Hamel, Marvin J Fritzler, Edward K L Chan.   

Abstract

GW bodies (GWBs), or mammalian P bodies, proposed to be involved in messenger RNA storage and/or degradation, have recently been linked to RNA interference and microRNA (miRNA) processing. We report that endogenous let-7 miRNA co-precipitates with the GW182 protein complex. In addition, knockdown of two proteins, Drosha and its protein partner DGCR8, which are vital to the generation of mature miRNA, results in the loss of GWBs. Subsequent introduction of short interference RNA specific to lamin A/C is accompanied by reassembly of GWBs and concurrent knockdown of lamin A/C protein. Taken together, these studies show that miRNAs are crucial components in GWB formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16906129      PMCID: PMC1559661          DOI: 10.1038/sj.embor.7400783

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  36 in total

1.  Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs.

Authors:  Rui Yi; Yi Qin; Ian G Macara; Bryan R Cullen
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

2.  MicroRNA genes are transcribed by RNA polymerase II.

Authors:  Yoontae Lee; Minju Kim; Jinju Han; Kyu-Hyun Yeom; Sanghyuk Lee; Sung Hee Baek; V Narry Kim
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

3.  The Microprocessor complex mediates the genesis of microRNAs.

Authors:  Richard I Gregory; Kai-Ping Yan; Govindasamy Amuthan; Thimmaiah Chendrimada; Behzad Doratotaj; Neil Cooch; Ramin Shiekhattar
Journal:  Nature       Date:  2004-11-07       Impact factor: 49.962

4.  Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs.

Authors:  Xuezhong Cai; Curt H Hagedorn; Bryan R Cullen
Journal:  RNA       Date:  2004-11-03       Impact factor: 4.942

5.  GW182 is critical for the stability of GW bodies expressed during the cell cycle and cell proliferation.

Authors:  Zheng Yang; Andrew Jakymiw; Malcolm R Wood; Theophany Eystathioy; Robert L Rubin; Marvin J Fritzler; Edward K L Chan
Journal:  J Cell Sci       Date:  2004-10-19       Impact factor: 5.285

6.  Nuclear export of microRNA precursors.

Authors:  Elsebet Lund; Stephan Güttinger; Angelo Calado; James E Dahlberg; Ulrike Kutay
Journal:  Science       Date:  2003-11-20       Impact factor: 47.728

7.  Identification of Edc3p as an enhancer of mRNA decapping in Saccharomyces cerevisiae.

Authors:  Meenakshi Kshirsagar; Roy Parker
Journal:  Genetics       Date:  2004-02       Impact factor: 4.562

8.  The GW182 protein colocalizes with mRNA degradation associated proteins hDcp1 and hLSm4 in cytoplasmic GW bodies.

Authors:  Theophany Eystathioy; Andrew Jakymiw; Edward K L Chan; Bertrand Séraphin; Nicolas Cougot; Marvin J Fritzler
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

9.  A mouse cytoplasmic exoribonuclease (mXRN1p) with preference for G4 tetraplex substrates.

Authors:  V I Bashkirov; H Scherthan; J A Solinger; J M Buerstedde; W D Heyer
Journal:  J Cell Biol       Date:  1997-02-24       Impact factor: 10.539

10.  Cytoplasmic foci are sites of mRNA decay in human cells.

Authors:  Nicolas Cougot; Sylvie Babajko; Bertrand Séraphin
Journal:  J Cell Biol       Date:  2004-04-05       Impact factor: 10.539

View more
  49 in total

Review 1.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

2.  Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells.

Authors:  Andrew Jakymiw; Rushi S Patel; Natasha Deming; Indraneel Bhattacharyya; Priya Shah; Richard J Lamont; Carol M Stewart; Donald M Cohen; Edward K L Chan
Journal:  Genes Chromosomes Cancer       Date:  2010-06       Impact factor: 5.006

3.  Detection of the argonaute protein Ago2 and microRNAs in the RNA induced silencing complex (RISC) using a monoclonal antibody.

Authors:  Keigo Ikeda; Minoru Satoh; Kaleb M Pauley; Marvin J Fritzler; Westley H Reeves; Edward K L Chan
Journal:  J Immunol Methods       Date:  2006-10-04       Impact factor: 2.303

4.  P-body formation is a consequence, not the cause, of RNA-mediated gene silencing.

Authors:  Ana Eulalio; Isabelle Behm-Ansmant; Daniel Schweizer; Elisa Izaurralde
Journal:  Mol Cell Biol       Date:  2007-04-02       Impact factor: 4.272

Review 5.  Protein interactions and complexes in human microRNA biogenesis and function.

Authors:  Marjorie P Perron; Patrick Provost
Journal:  Front Biosci       Date:  2008-01-01

6.  Target-specific requirements for enhancers of decapping in miRNA-mediated gene silencing.

Authors:  Ana Eulalio; Jan Rehwinkel; Mona Stricker; Eric Huntzinger; Schu-Fee Yang; Tobias Doerks; Silke Dorner; Peer Bork; Michael Boutros; Elisa Izaurralde
Journal:  Genes Dev       Date:  2007-09-27       Impact factor: 11.361

Review 7.  RNA granules: post-transcriptional and epigenetic modulators of gene expression.

Authors:  Paul Anderson; Nancy Kedersha
Journal:  Nat Rev Mol Cell Biol       Date:  2009-06       Impact factor: 94.444

8.  Identification of GW182 and its novel isoform TNGW1 as translational repressors in Ago2-mediated silencing.

Authors:  Songqing Li; Shang L Lian; Joanna J Moser; Mark L Fritzler; Marvin J Fritzler; Minoru Satoh; Edward K L Chan
Journal:  J Cell Sci       Date:  2008-12-15       Impact factor: 5.285

9.  Dcp1-bodies in mouse oocytes.

Authors:  Adam Swetloff; Beatrice Conne; Joachim Huarte; Jean-Luc Pitetti; Serge Nef; Jean-Dominique Vassalli
Journal:  Mol Biol Cell       Date:  2009-10-07       Impact factor: 4.138

Review 10.  Quantifying Argonaute proteins in and out of GW/P-bodies: implications in microRNA activities.

Authors:  Anthony K L Leung; Phillip A Sharp
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.